Benefits
Ashwagandha root extract studied for stress, cravings and body weight
In an 8-week randomized, double-blind, placebo-controlled trial in 52 adults under chronic stress, an ashwagandha root extract at 300 mg twice daily improved perceived stress scores, food cravings and eating-behaviour scores, and lowered body weight and BMI. That trial did not name Sensoril and did not test the SensorilTrim combination, so this is evidence for ashwagandha in general, in stressed adults, not for this branded blend.
Cortisol Balance
In the same 52-person trial, serum cortisol fell more with ashwagandha than with placebo over 8 weeks. The extract used was not identified as Sensoril, the participants were selected for chronic stress, and the trial did not measure belly fat or fat distribution, so any link to where fat sits on the body is an assumption rather than a finding.
Cardiovascular Risk Factor Support
In a 12-week single-group study with no placebo arm in overweight and class-1 obese adults, Capros amla at 500 mg twice daily lowered LDL cholesterol, the total-cholesterol-to-HDL ratio and the inflammation marker hs-CRP. Oxidized LDL was not among the reported measures, and the study tested Capros on its own, a different branded ingredient, not SensorilTrim.
Antioxidant Defense
Amla fruit is rich in polyphenols, and antioxidant activity is the usual explanation offered for its effects. Two placebo-controlled trials of Capros amla alone reported lower malondialdehyde and higher glutathione, but no study has measured antioxidant markers with the SensorilTrim blend, so treat this as unproven for the product.
Blood lipid support from the amla component (Capros)
Tested as Capros amla alone, not the SensorilTrim blend. In two small trials from one Indian group, 12 weeks of 250 or 500 mg twice daily beat placebo on LDL, triglycerides and HDL in 59 adults with metabolic syndrome (LDL down about 22% from baseline at 500 mg), and 500 mg twice daily lowered HbA1c versus placebo in 80 metformin-treated adults with type 2 diabetes. The maker supplied the capsules. A blend serving may hold less amla.
Mechanism of action
HPA-Axis Modulation (Ashwagandha)
Withanolides are thought to act on the body's stress-hormone system. In the one human trial cited here, an ashwagandha root extract lowered serum cortisol compared with placebo in 52 chronically stressed adults over 8 weeks. That extract was not identified as Sensoril, and the trial did not measure central body fat, so the step from cortisol to belly fat remains an untested idea.
Lipid and Inflammatory Pathway Effects (Amla)
In overweight and class-1 obese adults, Capros amla lowered LDL cholesterol and high-sensitivity C-reactive protein and reduced both ADP- and collagen-induced platelet aggregation. Reduced platelet aggregation means blood clots a little less readily, which matters if you take blood thinners or have surgery coming up. This was a separate study of Capros, not of SensorilTrim.
Oxidative Stress Reduction
Both plants show antioxidant activity in laboratory testing. In two placebo-controlled trials, Capros amla alone lowered malondialdehyde and raised glutathione; the ashwagandha trial measured no antioxidant marker, and the SensorilTrim blend itself is untested on this pathway.
Clinical trials
Randomized, double-blind, placebo-controlled trial of ashwagandha root extract 300 mg twice daily versus placebo for 8 weeks in 52 adults under chronic stress. Outcomes: perceived stress, food cravings, body weight, BMI, cortisol, eating behaviors.
52 chronically stressed adults, 8-week intervention.
Ashwagandha reduced perceived stress, food cravings and serum cortisol compared with placebo, and improved body weight, BMI, eating-behaviour scores and happiness scores. It was well tolerated. Limitations to keep in mind: only 52 people, only 8 weeks, and everyone was selected for chronic stress, so the results may not carry over to people who are not under that kind of stress. The extract was not identified as Sensoril and the SensorilTrim combination was not tested, and the dose used, 300 mg twice daily, is higher than the 125-250 mg of Sensoril twice daily usually listed.
Single-group study with no placebo arm: Capros (Phyllanthus emblica) 500 mg twice daily for 12 weeks in overweight or class-1 obese adults, with results compared against two averaged baseline visits; the lipid results came from only 9 people. Partly funded by Natreon, the maker. Outcomes: LDL, HDL, total cholesterol/HDL ratio, hs-CRP and platelet aggregation.
Overweight or class-1 obese adults, 12-week intervention with 2-week washout.
Capros amla lowered LDL cholesterol, the total-cholesterol-to-HDL ratio and hs-CRP, and reduced both ADP- and collagen-induced platelet aggregation. Two things to keep in mind: this tested Capros amla on its own, a different branded ingredient from SensorilTrim, and the drop in platelet aggregation means blood clots less readily, which is a bleeding consideration for anyone on blood thinners or heading into surgery.